- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/02 - Recovery or purification
Patent holdings for IPC class C12N 7/02
Total number of patents in this class: 1069
10-year publication summary
|
52
|
66
|
72
|
65
|
80
|
71
|
58
|
68
|
51
|
60
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bavarian Nordic A/S | 267 |
22 |
| The Trustees of the University of Pennsylvania | 4441 |
18 |
| Cytiva BioProcess R&D AB | 322 |
11 |
| Genzyme Corporation | 1381 |
10 |
| Sartorius Stedim Biotech GmbH | 887 |
10 |
| Valneva Austria GmbH | 120 |
9 |
| Novartis AG | 10172 |
8 |
| Seqirus UK Limited | 429 |
8 |
| The Regents of the University of California | 20924 |
7 |
| Kaneka Corporation | 4822 |
7 |
| University of Florida Research Foundation, Inc. | 4215 |
7 |
| BIA Separations d.o.o. | 16 |
7 |
| The Children's Hospital of Philadelphia | 875 |
7 |
| Crucell Holland B.V. | 72 |
7 |
| Janssen Vaccines & Prevention B.V. | 266 |
7 |
| Ultragenyx Pharmaceutical Inc. | 192 |
7 |
| uniQure Biopharma B.V. | 130 |
7 |
| uniQure IP B.V. | 87 |
7 |
| Japan Science and Technology Agency | 1207 |
6 |
| Association Francaise Contre Les Myopathies | 129 |
6 |
| Other owners | 891 |